Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.

Technology in cancer research & treatment - 1 Jan 2000

Zhang Qiang, Liu Xiao-Jun, Li Yang, Ying Xiao-Wei, Chen Lu

Abstract excerpt

LncRNA SET-binding factor 2 (SBF2) antisense RNA1 (SBF2-AS1) has been proven to play an oncogenic role in various types of tumors, but the prognostic role of SBF2-AS1 in tumors, especially in diffuse lower-grade glioma (LGG), is still unclear. Here, we aimed to investigate the prognostic value of SBF2-AS1 in LGG. The LGG expression profiles from The Cancer Genome Atlas (TCGA, n = 524) and Chinese Glioma Genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Central Nervous System Neoplasms
Share to Glioma
Share to Immunity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Kaplan-Meier Estimate

Share to Neoplasm Grading

Share to Proportional Hazards Models

Share to RNA, Long Noncoding

Source

Open in PubMed Open full text

Identifiers

PMID: 34159865
DOI: 10.1177/15330338211011966
PMCID: PMC8226362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.PMID 34159865Read ↗

Identification and Validation of RNA Methylation-Related Related Alternative Splicing Gene Signature for Low Grade Glioma to Predict Survival and Immune LandscapesSemantic proximity Read ↗

CSRP2 is involved in immune regulation and drug sensitivity in glioma cells by the LEF1- AS1/miR-128-3p/CSRP2 axisSemantic proximity Read ↗

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse gliomaSemantic proximity Read ↗

Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale AnalysisSemantic proximity Read ↗

DSN1 may predict poor prognosis of lower-grade glioma patients and may be a potential target for immunotherapySemantic proximity Read ↗

Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on the m6A-regulated GenesSemantic proximity Read ↗

Developing a Novel Prognostic Model for Low-grade Glioma Based on m6A-Associated Immune Genes and Identifying a New BiomarkerSemantic proximity Read ↗

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomasSemantic proximity Read ↗

Classification of diffuse lower‐grade glioma based on immunological profilingSemantic proximity Read ↗

Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of TumorsSemantic proximity Read ↗

Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.Semantic proximity Read ↗

RNA Binding Protein-Mediated Immunosuppressive Tumor Microenvironment Contributes to Poor Prognosis in High-Grade GliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.